Shengshiform sandbox
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Shengshiform sandbox is a Calcium Channel Blocker that is FDA approved for the {{{indicationType}}} of hypertension. Common adverse reactions include .
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Shengshiform sandbox FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Felodipine sandbox in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Safety and effectiveness in pediatric patients have not been established.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Felodipine sandbox in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Felodipine sandbox in pediatric patients.
Contraindications
Felodipine extended-release tablets are contraindicated in patients who are hypersensitive to this product.
Warnings
There is limited information regarding Shengshiform sandbox Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Shengshiform sandbox Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Shengshiform sandbox Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Shengshiform sandbox Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA): C
There is no FDA guidance on usage of Shengshiform sandbox in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Shengshiform sandbox in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Shengshiform sandbox during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Shengshiform sandbox in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Shengshiform sandbox in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Shengshiform sandbox in geriatric settings.
Gender
There is no FDA guidance on the use of Shengshiform sandbox with respect to specific gender populations.
Race
(Description)
Renal Impairment
(Description)
Hepatic Impairment
(Description)
Females of Reproductive Potential and Males
(Description)
Immunocompromised Patients
(Description)
Others
(Description)
Administration and Monitoring
Administration
Oral
Monitoring
FDA Package Insert for Felodipine contains no information regarding drug monitoring.
IV Compatibility
There is limited information about the IV Compatibility.
Overdosage
There is limited information regarding Shengshiform sandbox overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Shengshiform sandbox Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Shengshiform sandbox Mechanism of Action in the drug label.
Structure
There is limited information regarding Shengshiform sandbox Structure in the drug label.
Pharmacodynamics
There is limited information regarding Shengshiform sandbox Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Shengshiform sandbox Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Shengshiform sandbox Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Shengshiform sandbox Clinical Studies in the drug label.
How Supplied
There is limited information regarding Shengshiform sandbox How Supplied in the drug label.
Storage
There is limited information regarding Shengshiform sandbox Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Shengshiform sandbox |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Shengshiform sandbox |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Shengshiform sandbox Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Shengshiform sandbox interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Shengshiform sandbox Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Shengshiform sandbox Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
{{#subobject:
|Page Name=Shengshiform sandbox |Pill Name=No_image.jpg |Drug Name=FELODIPINE 2.5 mg |Pill Ingred=polyoxyl 40 hydrogenated castor oil, magnesium aluminum silicate, hypromellose 2208 (15000 mpa.s), lactose monohydrate, hydroxypropyl cellulose, sodium stearyl fumarate, hypromellose 2910 (5 mpa.s), titanium dioxide, polyethylene glycol 400, ferric oxide yellow, d&c yellow no. 10|+sep=; |Pill Imprint=I31 |Pill Dosage=2.5 mg |Pill Color=Yellow|+sep=; |Pill Shape=Round |Pill Size (mm)=11.00 |Pill Scoring=1 |Pill Image= |Drug Author=HERITAGE PHARMACEUTICALS INC. |NDC=23155-048
}}
{{#subobject:
|Page Name=Shengshiform sandbox |Pill Name=No_image.jpg |Drug Name=FELODIPINE 5 mg |Pill Ingred=polyoxyl 40 hydrogenated castor oil, magnesium aluminum silicate, hypromellose 2208 (15000 mpa.s), lactose monohydrate, hydroxypropyl cellulose, sodium stearyl fumarate, hypromellose 2910 (5 mpa.s), titanium dioxide, polyethylene glycol 400, ferric oxide yellow, d&c yellow no. 10|+sep=; |Pill Imprint=I32 |Pill Dosage=5 mg |Pill Color=Yellow|+sep=; |Pill Shape=Round |Pill Size (mm)=11.00 |Pill Scoring=1 |Pill Image= |Drug Author=HERITAGE PHARMACEUTICALS INC. |NDC=23155-049
}}
{{#subobject:
|Page Name=Shengshiform sandbox |Pill Name=No_image.jpg |Drug Name=FELODIPINE 10 mg |Pill Ingred=polyoxyl 40 hydrogenated castor oil, magnesium aluminum silicate, hypromellose 2208 (15000 mpa.s), lactose monohydrate, hydroxypropyl cellulose, sodium stearyl fumarate, hypromellose 2910 (5 mpa.s), titanium dioxide, polyethylene glycol 400, ferric oxide yellow, d&c yellow no. 10|+sep=; |Pill Imprint=I33 |Pill Dosage=10 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=11.00 |Pill Scoring=1 |Pill Image= |Drug Author=HERITAGE PHARMACEUTICALS INC. |NDC=23155-050
}}
{{#subobject:
|Label Page=Shengshiform sandbox |Label Name=Felodipine label 01.jpg
}}
{{#subobject:
|Label Page=Shengshiform sandbox |Label Name=Felodipine label 02.jpg
}}
{{#subobject:
|Label Page=Shengshiform sandbox |Label Name=Felodipine label 03.jpg
}}
{{#subobject:
|Label Page=Shengshiform sandbox |Label Name=Felodipine panel 01.png
}}
{{#subobject:
|Label Page=Shengshiform sandbox |Label Name=Felodipine panel 02.png
}}
{{#subobject:
|Label Page=Shengshiform sandbox |Label Name=Felodipine panel 03.png
}}